STOCK TITAN

Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Electromed, Inc. announced that its President and CEO, Jim Cunniff, and CFO, Brad Nagel, will attend the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum on November 16, 2023 in New York City. The management team will engage in investor 1x1s on the same day.
Positive
  • None.
Negative
  • None.

NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Jim Cunniff, President and Chief Executive Officer, and Brad Nagel, Chief Financial Officer, are scheduled to attend the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 16, 2023 at the Westin NY Grand Central in New York City.

Electromed’s management team will engage in investor 1x1s on Thursday, November 16, 2023.

About Electromed, Inc.

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

Brad Nagel, Chief Financial Officer

(952) 758-9299

investorrelations@electromed.com

Mike Cavanaugh, Investor Relations

ICR Westwicke

(617) 877-9641

mike.cavanaugh@westwicke.com

Source: Electromed, Inc.

FAQ

Who is attending the Canaccord Genuity MedTech, Diagnostics, and Digital Health & Services Forum?

Electromed, Inc.'s President and CEO, Jim Cunniff, and CFO, Brad Nagel, will be attending.

When and where will the forum take place?

The forum will take place on November 16, 2023, at the Westin NY Grand Central in New York City.

What activities will Electromed's management team participate in?

The management team will engage in investor 1x1s on Thursday, November 16, 2023.

Electromed, Inc.

NYSE:ELMD

ELMD Rankings

ELMD Latest News

ELMD Stock Data

253.39M
6.69M
27.77%
36.07%
1.73%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States of America
NEW PRAGUE